Aki Furusawa

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 23

Top Topics

Regulatory T Cells

Fluorescence Imaging

Top Venues

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Fuyuki F Inagaki, Makoto Kano, Aki Furusawa, Takuya Kato, Ryuhei Okada, Hiroshi Fukushima, Seiichiro Takao, Shuhei Okuyama, Peter L Choyke, Hisataka Kobayashi
Near-infrared photoimmunotherapy targeting PD-L1: Improved efficacy by preconditioning the tumor microenvironment. Cancer science 115 (7) (2024)
Fuyuki F Inagaki, Makoto Kano, Aki Furusawa, Takuya Kato, Ryuhei Okada, Hiroshi Fukushima, Seiichiro Takao, Shuhei Okuyama, Peter L Choyke, Hisataka Kobayashi
Near-infrared photoimmunotherapy targeting PD-L1: Improved efficacy by preconditioning the tumor microenvironment. Cancer science 115 (7) (2024)
Fuyuki F Inagaki, Makoto Kano, Aki Furusawa, Takuya Kato, Ryuhei Okada, Hiroshi Fukushima, Seiichiro Takao, Shuhei Okuyama, Peter L Choyke, Hisataka Kobayashi
Near-infrared photoimmunotherapy targeting PD-L1: Improved efficacy by preconditioning the tumor microenvironment. Cancer science 115 (7) (2024)
Fuyuki F Inagaki, Makoto Kano, Aki Furusawa, Takuya Kato, Ryuhei Okada, Hiroshi Fukushima, Seiichiro Takao, Shuhei Okuyama, Peter L Choyke, Hisataka Kobayashi
Near-infrared photoimmunotherapy targeting PD-L1: Improved efficacy by preconditioning the tumor microenvironment. Cancer science 115 (7) (2024)
Fuyuki F Inagaki, Makoto Kano, Aki Furusawa, Takuya Kato, Ryuhei Okada, Hiroshi Fukushima, Seiichiro Takao, Shuhei Okuyama, Peter L Choyke, Hisataka Kobayashi
Near-infrared photoimmunotherapy targeting PD-L1: Improved efficacy by preconditioning the tumor microenvironment. Cancer science 115 (7) (2024)
Fuyuki F Inagaki, Makoto Kano, Aki Furusawa, Takuya Kato, Ryuhei Okada, Hiroshi Fukushima, Seiichiro Takao, Shuhei Okuyama, Peter L Choyke, Hisataka Kobayashi
Near-infrared photoimmunotherapy targeting PD-L1: Improved efficacy by preconditioning the tumor microenvironment. Cancer science (2024)
Seiichiro Takao, Hiroshi Fukushima, A Paden King, Takuya Kato, Aki Furusawa, Shuhei Okuyama, Makoto Kano, Peter L Choyke, Freddy E Escorcia, Hisataka Kobayashi
Near-infrared photoimmunotherapy in the models of hepatocellular carcinomas using cetuximab-IR700. Cancer science (2023)
Hiroshi Fukushima, Aki Furusawa, Takuya Kato, Hiroaki Wakiyama, Seiichiro Takao, Shuhei Okuyama, Peter C Black, Hisataka Kobayashi
Intratumoral interleukin-15 improves efficacy of near-infrared photoimmunotherapy. Molecular cancer therapeutics (2023)
Nanami L Miyazaki, Aki Furusawa, Peter C Black, Hisataka Kobayashi
Review of RM-1929 Near-Infrared Photoimmunotherapy Clinical Efficacy for Unresectable and/or Recurrent Head and Neck Squamous Cell Carcinoma. Cancers 15 (21) (2023)
Hiroaki Wakiyama, Takuya Kato, Aki Furusawa, Ryuhei Okada, Fuyuki F Inagaki, Hideyuki Furumoto, Hiroshi Fukushima, Shuhei Okuyama, Peter C Black, Hisataka Kobayashi
Treg-Dominant Tumor Microenvironment Is Responsible for Hyperprogressive Disease after PD-1 Blockade Therapy. Cancer immunology research 10 (11) (2022)
Hiroshi Fukushima, Baris Turkbey, Peter A Pinto, Aki Furusawa, Peter C Black, Hisataka Kobayashi
Near-Infrared Photoimmunotherapy (NIR-PIT) in Urologic Cancers. Cancers 14 (12) (2022)
Hideyuki Furumoto, Takuya Kato, Hiroaki Wakiyama, Aki Furusawa, Peter L Choyke, Hisataka Kobayashi
Endoscopic Applications of Near-Infrared Photoimmunotherapy (NIR-PIT) in Cancers of the Digestive and Respiratory Tracts. Biomedicines 10 (4) (2022)
Fuyuki F Inagaki, Takuya Kato, Aki Furusawa, Ryuhei Okada, Hiroaki Wakiyama, Hideyuki Furumoto, Shuhei Okuyama, Peter C Black, Hisataka Kobayashi
Disialoganglioside GD2-Targeted Near-Infrared Photoimmunotherapy (NIR-PIT) in Tumors of Neuroectodermal Origin. Pharmaceutics 14 (10) (2022)
Takuya Kato, Aki Furusawa, Ryuhei Okada, Fuyuki F Inagaki, Hiroaki Wakiyama, Hideyuki Furumoto, Hiroshi Fukushima, Shuhei Okuyama, Peter C Black, Hisataka Kobayashi
Near-Infrared Photoimmunotherapy Targeting Podoplanin-Expressing Cancer Cells and Cancer-Associated Fibroblasts. Molecular cancer therapeutics (2022)
Hiroshi Fukushima, Takuya Kato, Aki Furusawa, Ryuhei Okada, Hiroaki Wakiyama, Hideyuki Furumoto, Shuhei Okuyama, Eisaku Kondo, Peter L Choyke, Hisataka Kobayashi
Intercellular adhesion molecule-1-targeted near-infrared photoimmunotherapy of triple-negative breast cancer. Cancer science 113 (9) (2022)
Hideyuki Furumoto, Ryuhei Okada, Takuya Kato, Hiroaki Wakiyama, Fuyuki Inagaki, Hiroshi Fukushima, Shuhei Okuyama, Aki Furusawa, Peter C Black, Hisataka Kobayashi
Optimal Light Dose for hEGFR-Targeted Near-Infrared Photoimmunotherapy. Cancers 14 (16) (2022)
Aki Furusawa, Ryuhei Okada, Fuyuki Inagaki, Hiroaki Wakiyama, Takuya Kato, Hideyuki Furumoto, Hiroshi Fukushima, Shuhei Okuyama, Peter L Choyke, Hisataka Kobayashi
CD29 targeted near-infrared photoimmunotherapy (NIR-PIT) in the treatment of a pigmented melanoma model. Oncoimmunology 11 (1) (2022)
Takuya Kato, Hiroaki Wakiyama, Aki Furusawa, Peter L Choyke, Hisataka Kobayashi
Near Infrared Photoimmunotherapy; A Review of Targets for Cancer Therapy. Cancers 13 (11) (2021)
Takuya Kato, Ryuhei Okada, Aki Furusawa, Fuyuki Inagaki, Hiroaki Wakiyama, Hideyuki Furumoto, Shuhei Okuyama, Hiroshi Fukushima, Peter C Black, Hisataka Kobayashi
Simultaneously Combined Cancer Cell- and CTLA4-Targeted NIR-PIT Causes a Synergistic Treatment Effect in Syngeneic Mouse Models. Molecular cancer therapeutics 20 (11) (2021)
Yutaka Kurebayashi, Colleen P Olkowski, Kelly C Lane, Olga V Vasalatiy, Biying C Xu, Ryuhei Okada, Aki Furusawa, Peter C Black, Hisataka Kobayashi, Noriko Sato
Rapid Depletion of Intratumoral Regulatory T Cells Induces Synchronized CD8 T- and NK-cell Activation and IFNγ-Dependent Tumor Vessel Regression. Cancer research 81 (11) (2021)
Hiroaki Wakiyama, Aki Furusawa, Ryuhei Okada, Fuyuki F Inagaki, Takuya Kato, Yasuhiro Maruoka, Peter L Choyke, Hisataka Kobayashi
Increased Immunogenicity of a Minimally Immunogenic Tumor after Cancer-Targeting Near Infrared Photoimmunotherapy. Cancers 12 (12) (2020)
Yasuhiro Maruoka, Aki Furusawa, Ryuhei Okada, Fuyuki F Inagaki, Hiroaki Wakiyama, Takuya Kato, Tadanobu Nagaya, Peter L Choyke, Hisataka Kobayashi
Interleukin-15 after Near-Infrared Photoimmunotherapy (NIR-PIT) Enhances T Cell Response against Syngeneic Mouse Tumors. Cancers 12 (9) (2020)
Yasuhiro Maruoka, Aki Furusawa, Ryuhei Okada, Fuyuki F Inagaki, Daiki Fujimura, Hiroaki Wakiyama, Takuya Kato, Tadanobu Nagaya, Peter L Choyke, Hisataka Kobayashi
Near-Infrared Photoimmunotherapy Combined with CTLA4 Checkpoint Blockade in Syngeneic Mouse Cancer Models. Vaccines 8 (3) (2020)